Lantus SoloSTAR Pens contain injectable insulin glargine, which is a form of regular human insulin that has been modified to increase the duration of action. It is also known as a basal insulin as it provides insulin coverage consistently for a full day after a single daily injection. For every package of the Lantus SoloSTAR Pen, there are five insulin pens with 3ml of insulin glargine with a concentration of 100 units/ml.
Lantus SoloSTAR Pen is used for both Type 1 and Type 2 diabetes mellitus, and also for neonatal diabetes mellitus. Lantus SoloSTAR Pens are typically used with oral antidiabetic medications such as metformin and other insulin injection types such as fast-acting (e.g. insulin aspart) or intermediate-acting insulin (e.g. insulin aspart protamine). This is to help ensure that the blood sugar levels remain within the normal range throughout the day, especially after meals.
Insulin glargine in the Lantus SoloSTAR Pen has a relatively consistent concentration over time that closely mimics the normal physiological release of insulin in the human body, so patients can expect a lower risk of hypoglycemia. Additionally, the pen can be used with ultra-fine needles that make the injection process less painful. The font used in the dosing window is largely printed and clearly displayed, which helps ensure the correct dose. The turn-based mechanism to adjust the dose and the push-button injection feature are ergonomically constructed to ensure ease-of-use.
Insulin glargine permits a once daily administration, it has less variability in its action in different patients, and has a significantly lower risk of hypoglycemia, especially nocturnal and severe hypoglycemia. Patients on other forms of insulin are also more prone to weight gain issues. Not to mention that you can receive greater discounts if you buy more than one Lantus SoloSTAR Pen at a time.